TL;DR
This study compares the diagnostic accuracy of high-frequency ultrasound (HFUS) and fiberoptic ductoscopy (FDS) for pathologic nipple discharge (PND). While both methods show promise, combining HFUS with FDS significantly improves diagnostic accuracy, suggesting a synergistic approach for better patient outcomes.
What Problem Does This Paper Address?
Pathologic nipple discharge (PND) is a concerning symptom that can indicate underlying breast issues, including malignancy. Accurately diagnosing the cause of PND is crucial for appropriate treatment. Current diagnostic methods, such as galactography, MRI, fiberoptic ductoscopy (FDS), and ultrasonography (US), have varying levels of effectiveness. FDS offers direct visualization but is invasive and time-consuming. High-frequency ultrasound (HFUS) is non-invasive and widely accepted, but its diagnostic value for PND needs further comparison with FDS. This paper aims to bridge this gap by directly comparing the diagnostic accuracy of HFUS and FDS, and evaluating the benefit of combining them, to guide clinical decision-making.
Methods
The study retrospectively analyzed data from 210 patients with PND who underwent both HFUS and FDS examinations. Pathological confirmation served as the gold standard for diagnosis.
- High-Frequency Ultrasound (HFUS): Performed using high-frequency color Doppler ultrasound machines (Philips IU22, GE S9, Mindray Resona7, Canon Aplio 500) with probe frequencies set between 5-10 MHz. The examination involved assessing ductal widening, wall smoothness, and the presence of space-occupying lesions, along with their morphology, margins, internal echoes, blood flow, and surrounding tissue changes.
- Fiberoptic Ductoscopy (FDS): Utilized the FVS-6000MI endoscopic imaging light source system. After local anesthesia and orifice dilation, the FDS scope was inserted to visualize the ductal wall structure and any space-occupying lesions. Lesion morphology, size, color, and activity were assessed.
- Pathological Confirmation: Achieved through ultrasound-guided core biopsy, local resection, or surgical resection.
- Statistical Analysis: Fisher's exact test and chi-squared (x²) test were employed to compare diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), with 95% confidence intervals calculated. A p-value < 0.05 was considered statistically significant.
Datasets
The study utilized data from 210 patients with PND treated at the authors' hospital between July 2013 and May 2021. A total of 248 lesions were analyzed. This is a retrospective dataset collected from a single institution.
Key Insights and Ideas
- Synergistic Power: The most significant finding is that combining HFUS and FDS dramatically increases diagnostic accuracy compared to either method alone. This highlights the complementary nature of these techniques.
- HFUS Strengths: HFUS excels in its non-invasive nature, providing good qualitative and localization information, especially for duct ectasia. It's a preferred initial evaluation tool.
- FDS Strengths: FDS offers direct visualization, leading to high diagnostic value, particularly in identifying intraductal lesions. Its specificity and PPV were notably high in this study.
- Limitations of Individual Methods: HFUS can be subjective and operator-dependent, and its resolution can be limited by artifacts. FDS, while direct, is invasive, time-consuming, and its reach is limited by scope diameter, potentially missing peripheral lesions.
- Clinical Pathway: The study suggests a clear clinical pathway: start with HFUS. If HFUS is inconclusive, consider FDS.
Key Results
- Overall Accuracy: HFUS achieved an overall diagnostic accuracy of 83.87% (208/248), while FDS achieved 85.08% (211/248). These differences were not statistically significant (P > 0.05).
- Combined Accuracy: The combination of HFUS and FDS yielded a significantly higher diagnostic accuracy of 93.14% (231/248) (x² = 10.91, P < 0.05).
- Malignancy Detection: All 16 malignant lesions were accurately diagnosed by HFUS. FDS missed one malignant lesion.
- Benign Lesion Detection: For the 232 benign lesions, HFUS accurately diagnosed 183, and FDS accurately diagnosed 196.
- Sensitivity and Specificity: HFUS sensitivity was 84.36% and specificity was 60%. FDS sensitivity was 86.83% and specificity was 100%.
Limitations and Future Work
- Limitations:
- The study was retrospective and conducted at a single center, which may limit generalizability.
- The diagnostic efficacy of HFUS can be influenced by the operator's experience and subjective judgment.
- The study notes that patients were asked not to apply pressure to the breast before FDS, which might have artificially inflated FDS's positive rate compared to HFUS.
- Missed diagnoses can occur in HFUS due to section thickness artifacts, especially when intraductal lesion echoes are similar to surrounding tissues.
- Future Work:
- The authors suggest performing HFUS gently to reduce probe pressure on the breast.
- They recommend visualizing dilated ducts as much as possible along their direction and performing multi-sectional scanning for dynamic observation of lesions.
- For patients where HFUS is inconclusive, combining it with FDS is recommended to significantly increase diagnostic accuracy.
Summary updated